Greyledge Technologies creating autologous biologic preparations, which enable physicians to optimize the practice of regenerative medicine.
Greyledge Technologies has raised $183K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in March 2025.
Greyledge Technologies is headquartered in Edwards, United States.
Greyledge Technologies creating autologous biologic preparations, which enable physicians to optimize the practice of regenerative medicine.
Greyledge Technologies is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Greyledge Technologies — Funding & Investors." VCBacked, March 18, 2025, https://www.vcbacked.co/company/greyledge-technologies. Accessed August 14, 2026.
VCBacked. (2025). Greyledge Technologies — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/greyledge-technologies
{{cite web |title=Greyledge Technologies — Funding & Investors |url=https://www.vcbacked.co/company/greyledge-technologies |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated